Evidence map›Paper›PMID 25347070›Full record

ArticlePloS one2014

Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.

Erik van Kampen, Olivier Beaslas, Reeni B Hildebrand, Bart Lammers, Theo J C Van Berkel, Vesa M Olkkonen, Miranda Van Eck

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Erik van KampenDiv. of Biopharmaceutics, Cluster of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Olivier BeaslasDept. of Lipid Signalling and Homeostasis, Minerva Foundation Institute for Medical Research, Helsinki, Finland.
Reeni B HildebrandDiv. of Biopharmaceutics, Cluster of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Bart LammersDiv. of Biopharmaceutics, Cluster of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Theo J C Van BerkelDiv. of Biopharmaceutics, Cluster of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Vesa M OlkkonenDept. of Lipid Signalling and Homeostasis, Minerva Foundation Institute for Medical Research, Helsinki, Finland.
Miranda Van EckDiv. of Biopharmaceutics, Cluster of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Centre for Human Drug Research · NLMinerva Foundation · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOxysterol binding protein Related Proteins (ORPs) mediate intracellular lipid transport and homeostatic regulation. ORP8 downregulates ABCA1 expression in macrophages and cellular cholesterol efflux to apolipoprotein A-I. In line, ORP8 knockout mice display increased amounts of HDL cholesterol in blood. However, the role of macrophage ORP8 in atherosclerotic lesion development is unknown. METHODS AND

resultsLDL receptor knockout (KO) mice were transplanted with bone marrow (BM) from ORP8 KO mice and C57Bl/6 wild type mice. Subsequently, the animals were challenged with a high fat/high cholesterol Western-type diet to induce atherosclerosis. After 9 weeks of Western-Type diet feeding, serum levels of VLDL cholesterol were increased by 50% in ORP8 KO BM recipients compared to the wild-type recipients. However, no differences were observed in HDL cholesterol. Despite the increase in VLDL cholesterol, lesions in mice transplanted with ORP8 KO bone marrow were 20% smaller compared to WT transplanted controls. In addition, ORP8 KO transplanted mice displayed a modest increase in the percentage of macrophages in the lesion as compared to the wild-type transplanted group. ORP8 deficient macrophages displayed decreased production of pro-inflammatory factors IL-6 and TNFα, decreased expression of differentiation markers and showed a reduced capacity to form foam cells in the peritoneal cavity.

conclusionsDeletion of ORP8 in bone marrow-derived cells, including macrophages, reduces lesion progression after 9 weeks of WTD challenge, despite increased amounts of circulating pro-atherogenic VLDL. Reduced macrophage foam cell formation and lower macrophage inflammatory potential are plausible mechanisms contributing to the observed reduction in atherosclerosis.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAtherosclerosisATP Binding Cassette Transporter 1BiomarkersBone Marrow CellsCD68 MoleculeCholesterolCytokinesDisease Models, AnimalFemaleFoam CellsGene ExpressionInflammation MediatorsLeukocyte CountAntigens, CDAntigens, Differentiation, MyelomonocyticATP Binding Cassette Transporter 1BiomarkersCD68 antigen, humanCD68 MoleculeCholesterolCytokinesInflammation MediatorsMustard GasOxysterol Binding ProteinsReceptors, LDLReceptors, SteroidTriglycerides

Identifiers

PMID25347070
PMCPMC4209969
OpenAlexW2051338299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.